927 related articles for article (PubMed ID: 11749701)
1. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
2. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
3. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
4. Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1alpha/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol.
Hur E; Kim HH; Choi SM; Kim JH; Yim S; Kwon HJ; Choi Y; Kim DK; Lee MO; Park H
Mol Pharmacol; 2002 Nov; 62(5):975-82. PubMed ID: 12391259
[TBL] [Abstract][Full Text] [Related]
5. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
6. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines.
Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL
Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
8. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro.
Pedersen MW; Holm S; Lund EL; Højgaard L; Kristjansen PE
Neoplasia; 2001; 3(1):80-7. PubMed ID: 11326319
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.
Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012
[TBL] [Abstract][Full Text] [Related]
10. The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia.
Maltepe E; Keith B; Arsham AM; Brorson JR; Simon MC
Biochem Biophys Res Commun; 2000 Jun; 273(1):231-8. PubMed ID: 10873592
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific antitumor activity of radicicol oxime derivatives.
Soga S; Sharma SV; Shiotsu Y; Shimizu M; Tahara H; Yamaguchi K; Ikuina Y; Murakata C; Tamaoki T; Kurebayashi J; Schulte TW; Neckers LM; Akinaga S
Cancer Chemother Pharmacol; 2001 Dec; 48(6):435-45. PubMed ID: 11800023
[TBL] [Abstract][Full Text] [Related]
12. Constitutive upregulation of hypoxia-inducible factor-1alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure.
Koshikawa N; Iyozumi A; Gassmann M; Takenaga K
Oncogene; 2003 Oct; 22(43):6717-24. PubMed ID: 14555985
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi R; Mookerjee B; Bhujwalla ZM; Sutter CH; Artemov D; Zeng Q; Dillehay LE; Madan A; Semenza GL; Bedi A
Genes Dev; 2000 Jan; 14(1):34-44. PubMed ID: 10640274
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia reduces hormone responsiveness of human breast cancer cells.
Kurebayashi J; Otsuki T; Moriya T; Sonoo H
Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor.
Karth J; Ferrer FA; Perlman E; Hanrahan C; Simons JW; Gearhart JP; Rodriguez R
J Pediatr Surg; 2000 Dec; 35(12):1749-53. PubMed ID: 11101729
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
[TBL] [Abstract][Full Text] [Related]
18. Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
Lee SH; Wolf PL; Escudero R; Deutsch R; Jamieson SW; Thistlethwaite PA
N Engl J Med; 2000 Mar; 342(9):626-33. PubMed ID: 10699162
[TBL] [Abstract][Full Text] [Related]
19. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.
Bos R; Zhong H; Hanrahan CF; Mommers EC; Semenza GL; Pinedo HM; Abeloff MD; Simons JW; van Diest PJ; van der Wall E
J Natl Cancer Inst; 2001 Feb; 93(4):309-14. PubMed ID: 11181778
[TBL] [Abstract][Full Text] [Related]
20. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.
Mabjeesh NJ; Escuin D; LaVallee TM; Pribluda VS; Swartz GM; Johnson MS; Willard MT; Zhong H; Simons JW; Giannakakou P
Cancer Cell; 2003 Apr; 3(4):363-75. PubMed ID: 12726862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]